Company Filing History:
Years Active: 2002-2003
Title: The Innovative Contributions of Michael Joseph Roth in Pharmaceutical Chemistry
Introduction
Michael Joseph Roth, an accomplished inventor based in Ontario, CA, has made significant strides in the field of pharmaceutical chemistry with a total of three patents to his name. His innovative work focuses on the synthesis of histamine dihydrochloride, a compound vital for various medical applications.
Latest Patents
One of Roth's key inventions includes a novel method for the preparation of pharmaceutical grades of histamine dihydrochloride. This two-step, non-enzymatic synthetic method involves the non-enzymatic decarboxylation of histidine, followed by the step-wise conversion of the decarboxylated product into the dihydrochloride salt form. The final product is meticulously crafted to ensure it meets pharmaceutical standards, containing less than 0.8% L-histidine HCl monohydrate, 0.1% individual chromatographic impurities, and 2% total impurities, thereby establishing its acceptability for pharmaceutical use.
Career Highlights
Roth plays an instrumental role at Maxim Pharmaceuticals, Inc., where he applies his expertise to advance pharmaceutical innovations. His commitment to research and development reflects in his patent contributions, which aim to enhance the quality and efficacy of pharmaceutical products.
Collaborations
Throughout his career, Roth has collaborated with notable colleagues such as Wen-Lung Yeh and Casimir Antczak. These partnerships have likely fostered a creative environment that encourages the development of groundbreaking solutions in medicinal chemistry.
Conclusion
Michael Joseph Roth's inventive spirit and dedication to pharmaceutical innovation have positioned him as a notable figure in his field. His patents not only contribute to scientific knowledge but also hold the potential to impact medical treatments positively. As he continues to work with Maxim Pharmaceuticals, Inc., the future looks promising for further advancements stemming from his innovative pursuits.